Overview

MGR001 / Advair Diskus Local Equivalence Study in Asthma

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MGR001 is equivalent to Advair Diskus when administered by inhalation in adult asthma patients
Phase:
Phase 3
Details
Lead Sponsor:
Mylan Inc.
Collaborator:
Mylan Pharmaceuticals
Treatments:
Fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Salmeterol Xinafoate
Xhance